Primary progressive aphasia (PPA) is a neurodegenerative disease that primarily affects language functions and often begins in the fifth or sixth decade of life. The devastating effects on work and home life call for the investigation of treatment alternatives. In this paper, we present a review of the literature on treatment approaches for this neurodegenerative disease. We also present new data from two intervention studies we have conducted, a behavioral one and a neuromodulatory one using transcranial direct current stimulation (tDCS) combined with written production intervention. We show that speechlanguage intervention improves language outcomes in individuals with PPA, and especially in the short term, tDCS augments generalization and maintenance of positive language outcomes. We also outline current issues and challenges in intervention approaches in PPA.
Introduction
Primary progressive aphasia (PPA) is a neurodegenerative syndrome that mainly affects language abilities, including word finding, word usage, word comprehension, and sentence construction [1•, 2•, 3•]. PPA is characterized by insidious onset and gradual deterioration of language associated with atrophy of the frontal and temporal regions of the left hemisphere [1•, 4] . In this neurodegenerative condition, Due to its onset in middle age, PPA profoundly i m p a c t s w o r k a n d h o m e l i f e . B e h a v i o r a l interventions-mainly for spoken naming-have been described to remediate the language deficits in PPA [25] [26] [27] 28 ••, 29 ••]. Word production impairments (both in oral and written modalities as manifested in deficits in picture naming and spelling) have important clinical value in PPA since they are the two earliest symptoms, thus allowing for early detection and intervention. Word finding and fluency difficulties are among the first symptoms in logopenic (lvPPA) and non-fluent (nfaPPA) variants [30] . Spelling is also impaired early in every subtype and may predict the PPA subtype early in the course of the disease [31•] . For example, surface dysgraphia symptoms are usually found in semantic variant (svPPA) or lvPPA but more rarely in nfaPPA. Those with nfaPPA sometimes rely on spelling when they eventually become mute [3•].
Cognitive mechanisms underlying spoken and written word production and implications for therapy In this section, we review the cognitive mechanisms involved in spoken and written production since spelling, naming, and reading deficits are among the first and most disruptive symptoms in PPA, and their remediation is the goal of most interventions. Figure 1 shows the close relationship between spoken and written word production mechanisms in models of cognitive architecture. Specifically, word representations in either the written or spoken modality may be accessed from the other modality or the semantic (word meaning) system [32, 33] . The implication, which is the basis of several treatment studies in post-stroke aphasia [34, 35] , is that both lexical and sublexical routes from one modality may contribute to word retrieval in the other. Thus, behavioral treatments stimulating residual knowledge across the semantic, phonological, and orthographic domains have resulted in cross-domain improvements [36] [37] [38] [39] . For example, a combination of spelling treatment with spoken repetition [37, 40, 41] improved written and spoken production even in participants with semantic impairments.
Spoken and written production intervention studies in PPA Intervention studies in PPA are, in general, difficult due to the degenerative nature of the disease, the variable rate of decline among individuals and the inherent heterogeneity of each variant. For example, individuals with nfaPPA decline more rapidly in action than object naming, while those with svPPA show the opposite pattern [42•] , and those with svPPA show most notable decline in object semantics [43, 44] . Therefore, most intervention studies are case reports or include a small number of participants (for a review, see [45••] [57] , repetition and writing tasks, as well as forced-choice recognition, were used. In the repetition treatment, participants viewed a picture and a string of symbols and repeated the picture label after a spoken presentation. In the writing treatment, participants viewed a picture and its corresponding printed label, and then copied the label. In both treatments, a forced-choice recognition task was used to ensure that participants attended to both the pictures and the words. This therapy facilitates naming by accessing phonology via the non-semantic or orthography route. Thus, there is an evidence base that a variety of methods are effective in facilitating naming performance. Speech-language pathologists must consider this evidence as well as individual patient needs, degree of deficit, and cognitive models of language processing when planning treatment [45••] .
Intervention studies in individuals with apraxia of speech (AOS) associated with nfaPPA, characterized by syntactic disorders and apraxia of speech (AOS) in the initial stages, have targeted the single-word level. A recent study used reading of multisyllabic words as an intervention strategy in PPA with lasting and generalizable results [58] .
Only two behavioral studies of which we are aware have examined treatment of written language in PPA-one treating sublexical mechanisms [29••] and the other treating lexical processes [28••] . Both treatments were successful, but long-term follow-up was examined only in one study [28••] and was successful only for treated items. These studies have shown that results with language therapy alone are encouraging although limited, either because they have not shown generalization to untrained items or because they have lacked follow-up to evaluate the sustainability of therapy gains. Transcranial direct current stimulation to augmenting language interventions Transcranial direct current stimulation (tDCS) has been identified as a promising intervention to augment behavioral treatment benefits in language therapy programs, mostly in stroke [ . The benefits of tDCS-its low expense, high safety profile, and noninvasive nature-justify research on its use in PPA as a possible means to augment behavioral intervention effects and reduce the rate of decline in language. The precise mechanisms of tDCS are unknown; however, it is thought that tDCS changes the membrane potentials of neurons in a relatively focal area of brain tissue under the skull [65••, 66, 67] . Anodal stimulation increases the likelihood of neural firing [67] . tDCS induces a subthreshold polarization of neurons too weak to generate action potentials, but sufficient to modulate the neuronal response threshold. Thus, tDCS alters the spontaneous firing rate of neurons to modulate their response to afferent signals [68] . These changes in response threshold correlate with task performance. Thus, increases or decreases in cortical excitability induced by tDCS are believed to promote longterm potentiation (LTP) and long-term depression (LTD). The brain mechanisms that induce such effects are thought to be late long-term potentiation and/or protein synthesis [71, 72••, 73, 74] , which may constitute the physiological basis of long-term memory formation and offline consolidation. Given that long-lasting learning reflects synaptic connectivity changes, the effects of tDCS are expected to be manifested in connectivity changes between nodes of neural networks. Indeed, studies that have looked at effects of tDCS on functional connectivity using resting-state fMRI (rsfMRI) have found significant changes in healthy controls [81] [82] [83] [84] [85] .
tDCS interventions in neurodegenerative disease tDCS has been shown to enhance cortical excitability and function [86, 87••, 88] when anodal current is applied in healthy individuals. Tasks employed in these studies include fluency, interference, picture naming, verbal learning, and proper noun learning. In clinical populations, tDCS has been used mainly to improve motor and language recovery, primarily after stroke [ . The tasks used in the tDCS studies were verbal and visual recognition memory in AD, spoken verbal fluency and naming in FTD, and spelling in our study in PPA. In the visual recognition memory task used in tDCS interventions in AD, two items (drawings of animals, persons and objects) were displayed on a computer screen for 10 s and then, 1 s later patients were shown a single picture and were asked to say whether the picture (test trial) had been presented before. The naming task used in the other FTD study [99••] comprised a picture naming task of black and white drawings of objects displayed on a computer screen. There were two balanced lists of pictures, treated and untreated stimuli that were further split and practiced in each week of treatment (2 weeks of treatment overall). Items were specifically tailored for each patient and practiced for 25 min during anodal tDCS or sham. Treatment included several steps to elicit the oral production of a target noun: repetition of the target word, oral picture naming, and reading of the target word. In our spelling study in PPA, we used a similar treatment protocol: two sets of ten letters and corresponding words (starting with the same grapheme) were selected as trained and untrained items, respectively. Different sets of letter-word correspondences were practiced in each period (sham or tDCS). Participants were randomized in either sham or anodal tDCS for the first period in a within-subject cross-over design. Each period lasted 3 weeks, thus they received tDCS or sham for 15 consecutive sessions. In each trial, participants were given a sound to which they had to find the corresponding letter and were asked to write a word starting from it. Written production of the target word was induced by repetition, reading, studying, and copying. Less-impaired participants were also encouraged to produce as many words as they could.
One FTD study [98••] did not find any effect of tDCS in improving verbal fluency which may have been because there was only one 40-min stimulation session that was not coupled with language therapy. In this study, spoken verbal fluency was used as a measurement but not as treatment. Other studies that did not couple tDCS with language therapy have repeatedly yielded no improvement in both healthy and patient populations [101] [102] [103] . A highly consistent finding across studies using a wide array of tasks is that tDCS-induced facilitation is highly dependent on the task subjects perform during stimulation and that tDCS-only conditions are consistently unsuccessful [101] [102] [103] [104] [105] .
We are aware of only three other neuromodulation studies in PPA; all three used repetitive transcranial magnetic stimulation (rTMS) [106, 107••, 108••] , and all showed improvement with neuromodulation during language therapy tasks. Of particular interest is Trebbastoni et al.'s case study [107••] in which after TMS stimulation during five consecutive sessions twice (interleaved with five sham stimulations) over the dorsolateral prefrontal cortex and close to the inferior frontal gyrus (IFG) and middle frontal gyrus (MFG), the PPA participant showed improvement in phonemic verbal fluency and written language (decrease of semantic and syntactic errors in sentences).
Long-term benefits of neuromodulation (tDCS or TMS) have not been clearly identified; this is especially true for neurodegenerative diseases. One study in AD showed improvement in naming one month after tDCS [78••] . In general, long-term effects-whenever shown-appeared after at least five consecutive days of stimulation. Determining the duration of therapeutic effects is critical, especially in neural degeneration, because it enables more effective planning of whether and when treatment should be repeated. In both recent studies using tDCS in PPA [99••, 100••], long-term effects (up to two months) have been identified, offering promise of the proposed intervention as a tool of slowing down the rate of decline in neurodegeneration.
Generalization of treatment gains to other language and cognitive functions In addition to generalization to untrained items, generalization to untrained tasks is expected, and sometimes observed when trained and untrained tasks share cognitive functions [34, 35] . Two studies in post-stroke aphasia evaluated tDCS effects of training oral naming [96] and syllable-word repetition [89••] and have shown generalization to written naming. In published interventions in PPA, these effects are not fully investigated. Future studies should test the hypothesis that gains from training both spoken and written word representations will generalize to related language and cognitive functions. Furthermore, since language and cognitive impairments associated with PPA interfere with activities in daily life and life satisfaction, future studies should evaluate how improvements in language and cognitive functions enhance quality of life for individuals with PPA and their families.
Medications
Because the most common pathology underlying lvPPA is Alzheimer's disease pathology, the decline in symptoms might be reduced with cholinesterase inhibitors and/or memantine, medications that have been shown to somewhat reduce the rate of decline in cognition in clinically diagnosed Alzheimer's disease. However, a large randomized clinical trial specifically in lvPPA has not been completed. Case studies have reported improvement in language with steroid treatment [109] or Omentum Transposition Therapy [110] , but these effects have not been replicated. Theoretically, medications that enhance neuroplasticity, such as selective serotonin reuptake inhibitors, might augment the effects of tDCS, but the combination of interventions has not been studied in PPA.
Conclusions: challenges and new venues
The present review shows that language interventions are possible and can be successful in a neurodegenerative disease. All behavioral interventions in PPA cited above showed improvement of the language function targeted. However, not all of them showed generalizable and long-lasting effects. Many reasons may be responsible for these findings: heterogeneity of symptoms and pathologies reflected by the different PPA variants, different stages of disease progression at baseline, and variable rate of decline between participants and studies. Neuromodulation with tDCS offers promise as a means of augmenting language therapy to improve written language function at least temporarily in PPA. The consistent finding of generalization of treatment benefits to untreated items and the superior sustainability of treatment effects with tDCS justifies further investigations. To date, there are only a few studies with small sample sizes, so results require caution in interpretation but offer hope for improved outcomes of combined language therapy and tDCS. Future interventions need to address particular challenges, such as ways to account for the variable effect of degeneration in each individual, generalization of treatment to other cognitive functions, and impact and improvement in quality of life of the individuals with PPA. Longitudinal studies also need to determine whether interventions have the potential of altering the rate of disease progression or even slowing down the progression of symptoms for some time. Future research is needed to determine whether medications, used alone or in combination with speech and language treatment with or without neuromodulation, can be of benefit in reducing the rate of language decline in PPA. Finally, future research should address the brain mechanisms involved in both behavioral and neuromodulatory interventions.
